GMP PAT Systems for Real-Time Pharmaceutical Quality Control
Implement Process Analytical Technology (PAT) with Bhutya Technologies—FDA-guided real-time monitoring delivering Quality by Design (QbD), continuous verification, and 21 CFR Part 11 compliance for Life Sciences manufacturing.
Why Choose Managed PAT Services
Struggling with at-line testing delays and batch variability? Our PAT implementations—NIR spectroscopy, Raman, pH probes, particle size analyzers—provide instantaneous process understanding and control.
Key PAT Benefits for Pharma Operations
50-70% reduction in batch rejections through real-time CPP/CQA monitoring
Continuous manufacturing enablement with real-time release testing (RTRT)
3x faster process development using Design Space modeling
Zero 483 observations via automated PAT validation lifecycle
PAT Framework Implementation
Complete QbD lifecycle—from Critical Quality Attribute identification to control strategy deployment.
Real-Time Release Testing (RTRT)
End-to-end continuous verification eliminating end-product testing.
Multivariate Data Analysis (MVDA)
Principal Component Analysis (PCA), Partial Least Squares (PLS) models for process prediction.
PAT + DCS Integration
Closed-loop control linking analyzers to DeltaV/DCS for automatic setpoint adjustment.
Predictable PAT Ownership Costs
Flat-rate PAT management eliminates expensive revalidation during process changes. 24/7 monitoring of spectral quality, calibration models, and analyzer health.
Near-Infrared (NIR) Spectroscopy
Real-time moisture, API content, polymorph detection in blenders and dryers.
Raman Spectroscopy
Non-destructive blend uniformity and endpoint detection.
Process Particle Size Analysis
FBRM/LASER diffraction for granulation endpoint determination.
pH/Conductivity/Dissolved Oxygen
Real-time bioreactor monitoring for cell culture optimization.
Multivariate Statistical Process Control
Hotelling T2, Squared Prediction Error (SPE) charts for process health.
24/7 PAT Operations Center
Global monitoring of signal-to-noise ratios, model prediction errors, and instrument uptime.
